Shares of Savaria Co. (TSE:SIS - Get Free Report) have been given a consensus recommendation of "Buy" by the ten ratings firms that are presently covering the company, MarketBeat.com reports. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is C$34.35.
A number of equities research analysts have recently commented on the stock. Ventum Financial set a C$34.50 price objective on shares of Savaria and gave the stock a "buy" rating in a research note on Thursday, September 10th. TD boosted their target price on shares of Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a research note on Friday, August 7th. TD Securities upgraded shares of Savaria to a "strong-buy" rating in a research note on Friday, July 24th. ATB Cormark Capital Markets increased their price target on shares of Savaria from C$35.00 to C$38.00 and gave the stock an "outperform" rating in a report on Friday, August 7th. Finally, Desjardins increased their price target on shares of Savaria from C$36.00 to C$39.00 and gave the stock a "buy" rating in a report on Friday, August 7th.
Check Out Our Latest Report on SIS
Savaria Price Performance
Shares of SIS opened at C$28.95 on Tuesday. The company has a market cap of C$2.09 billion, a price-to-earnings ratio of 23.93, a price-to-earnings-growth ratio of 42.72 and a beta of 0.80. Savaria has a twelve month low of C$20.72 and a twelve month high of C$31.95. The company has a quick ratio of 0.91, a current ratio of 1.72 and a debt-to-equity ratio of 29.43. The company has a 50 day moving average of C$28.94 and a two-hundred day moving average of C$29.04.
Savaria (TSE:SIS - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported C$0.35 EPS for the quarter. The firm had revenue of C$245.78 million for the quarter. Savaria had a return on equity of 13.41% and a net margin of 9.27%. As a group, analysts predict that Savaria will post 1.20 earnings per share for the current fiscal year.
Insider Buying and Selling at Savaria
In other news, insider Jean-Philippe De Montigny sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of C$29.21, for a total value of C$292,100.00. Following the transaction, the insider owned 82,560 shares in the company, valued at C$2,411,577.60. This trade represents a 10.80% decrease in their ownership of the stock. Also, Director Jean-Louis Chapdelaine sold 14,898 shares of the business's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of C$30.24, for a total transaction of C$450,515.52. Following the transaction, the director owned 100,000 shares in the company, valued at C$3,024,000. The trade was a 12.97% decrease in their ownership of the stock. Insiders have sold a total of 74,511 shares of company stock valued at $2,239,313 over the last ninety days. Corporate insiders own 17.45% of the company's stock.
Savaria Company Profile
(
Get Free Report)
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Savaria, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.
While Savaria currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.